Viva Biotech Holdings (VBIZF)
OTCMKTS · Delayed Price · Currency is USD
0.3150
-0.0094 (-2.90%)
At close: Aug 26, 2025
Viva Biotech Holdings Market Cap
Viva Biotech Holdings has a market cap or net worth of $695.80 million as of September 12, 2025. Its market cap has increased by 396.50% in one year.
Market Cap
695.80M
Enterprise Value
733.28M
Revenue
256.39M
Ranking
n/a
PE Ratio
28.93
Stock Price
$0.32
Market Cap Chart
Since May 9, 2019, Viva Biotech Holdings's market cap has decreased from 844.70M to 695.80M, a decrease of -17.63%. That is a compound annual growth rate of -3.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 695.80M | 197.40% |
| Dec 31, 2024 | 233.96M | -18.73% |
| Dec 29, 2023 | 287.88M | -33.04% |
| Dec 30, 2022 | 429.89M | -62.94% |
| Dec 31, 2021 | 1.16B | -48.59% |
| Dec 31, 2020 | 2.26B | 146.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 739.21M |
| Elite Pharmaceuticals | 737.49M |
| Glass House Brands | 577.09M |
| Northwest Biotherapeutics | 376.88M |
| CytoDyn | 367.97M |
| American Oncology Network | 353.19M |